187 related articles for article (PubMed ID: 24565579)
1. Genes and pathology of non-small cell lung carcinoma.
Sakashita S; Sakashita M; Sound Tsao M
Semin Oncol; 2014 Feb; 41(1):28-39. PubMed ID: 24565579
[TBL] [Abstract][Full Text] [Related]
2. Performance validation in anatomic pathology: successful integration of a new classification system into the practice setting using the updated lung non-small cell carcinoma recommendations.
Murugan P; Stevenson ME; Hassell LA
Arch Pathol Lab Med; 2014 Jan; 138(1):105-9. PubMed ID: 24377817
[TBL] [Abstract][Full Text] [Related]
3. [Small biopsies and cytologic specimens management in microscopic diagnosis and subtyping of non-small cell lung cancer, as recommended by IASLC/ATS/ERS].
Langfort R; Szołkowska M; Szczepulska-Wójcik E; Maksymiuk B
Pneumonol Alergol Pol; 2012; 80(2):172-7. PubMed ID: 22370987
[No Abstract] [Full Text] [Related]
4. The classification of lung carcinoma: time to change the morphology-based approach?
Pelosi G; Sonzogni A; Viale G
Int J Surg Pathol; 2010 Jun; 18(3):161-72. PubMed ID: 20460313
[TBL] [Abstract][Full Text] [Related]
5. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
[TBL] [Abstract][Full Text] [Related]
6. Template for reporting results of biomarker testing of specimens from patients with non-small cell carcinoma of the lung.
Cagle PT; Sholl LM; Lindeman NI; Alsabeh R; Divaris DX; Foulis P; Lee G; Neal JW; Nowak JA; Yu PP;
Arch Pathol Lab Med; 2014 Feb; 138(2):171-4. PubMed ID: 23808401
[No Abstract] [Full Text] [Related]
7. Subtyping non-small cell lung cancer: relevant issues and operative recommendations for the best pathology practice.
Rossi G; Pelosi G; Barbareschi M; Graziano P; Cavazza A; Papotti M
Int J Surg Pathol; 2013 Aug; 21(4):326-36. PubMed ID: 23740564
[TBL] [Abstract][Full Text] [Related]
8. Pathology of non-small cell lung cancer. New diagnostic approaches.
Linnoila I
Hematol Oncol Clin North Am; 1990 Dec; 4(6):1027-51. PubMed ID: 1962774
[TBL] [Abstract][Full Text] [Related]
9. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
10. Prospects for molecular staging of non-small-cell lung cancer from genomic alterations.
Tomaszek SC; Huebner M; Wigle DA
Expert Rev Respir Med; 2010 Aug; 4(4):499-508. PubMed ID: 20658911
[TBL] [Abstract][Full Text] [Related]
11. A reevaluation of the clinical significance of histological subtyping of non--small-cell lung carcinoma: diagnostic algorithms in the era of personalized treatments.
Rossi G; Pelosi G; Graziano P; Barbareschi M; Papotti M
Int J Surg Pathol; 2009 Jun; 17(3):206-18. PubMed ID: 19443885
[TBL] [Abstract][Full Text] [Related]
12. Implications for powering biomarker discovery studies.
Dibben SM; Holt RJ; Davison TS; Wilson CL; Taylor J; Paul I; McManus K; Kelly PJ; Proutski V; Harkin DP; Kerr P; Fennell DA; James JA; Kennedy RD
J Mol Diagn; 2012; 14(2):130-9. PubMed ID: 22251612
[TBL] [Abstract][Full Text] [Related]
13. DNA methylation of multiple genes and clinicopathological relationship of non-small cell lung cancers.
Hanabata T; Tsukuda K; Toyooka S; Yano M; Aoe M; Nagahiro I; Sano Y; Date H; Shimizu N
Oncol Rep; 2004 Jul; 12(1):177-80. PubMed ID: 15201980
[TBL] [Abstract][Full Text] [Related]
14. Common and contrasting genomic profiles among the major human lung cancer subtypes.
Tonon G; Brennan C; Protopopov A; Maulik G; Feng B; Zhang Y; Khatry DB; You MJ; Aguirre AJ; Martin ES; Yang Z; Ji H; Chin L; Wong KK; Depinho RA
Cold Spring Harb Symp Quant Biol; 2005; 70():11-24. PubMed ID: 16869734
[TBL] [Abstract][Full Text] [Related]
15. [Changes in classiffication of primary lung adenocarcinoma according to reccomendations of International Association for the Study of Lung Cancer/ /American Thoracic Society/European Respiratory Society].
Szołkowska M; Langfort R; Szczepulska-Wójcik E; Maksymiuk B
Pneumonol Alergol Pol; 2012; 80(2):163-71. PubMed ID: 22370986
[No Abstract] [Full Text] [Related]
16. [Value of combined detection of tumor markers for the prediction of small cell and non-small cell lung cancer].
Wu Y; Wu Y; Wang L; Qu L
Wei Sheng Yan Jiu; 2000 Jul; 29(4):213-5. PubMed ID: 12520921
[TBL] [Abstract][Full Text] [Related]
17. Genome-wide combination profiling of DNA copy number and methylation for deciphering biomarkers in non-small cell lung cancer patients.
Son JW; Jeong KJ; Jean WS; Park SY; Jheon S; Cho HM; Park CG; Lee HY; Kang J
Cancer Lett; 2011 Dec; 311(1):29-37. PubMed ID: 21757291
[TBL] [Abstract][Full Text] [Related]
18. New agents in advanced non-small-cell lung cancer treatment.
Ricciardi S; de Marinis F
Oncology; 2009; 77 Suppl 1():103-12. PubMed ID: 20130438
[TBL] [Abstract][Full Text] [Related]
19. The role of molecular analyses in the diagnosis and treatment of non-small-cell lung carcinomas.
Rossi G; Graziano P; Leone A; Migaldi M; Califano R
Semin Diagn Pathol; 2013 Nov; 30(4):298-312. PubMed ID: 24342286
[TBL] [Abstract][Full Text] [Related]
20. Tissue sampling in lung cancer: a review in light of the MERIT experience.
Reck M; Hermes A; Tan EH; Felip E; Klughammer B; Baselga J
Lung Cancer; 2011 Oct; 74(1):1-6. PubMed ID: 21658788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
